An unusual adverse effect of interferon: Hypertrichosis of the eyelashes

Journal of Interferon and Cytokine Research

Volumn 20, Issue 7, 2000, Pages 633-634

  Özdoǧan, Mete ^a,b   Gür, Gürden ^a   Kadayifcilar, Sibel ^a   Boyaciog̈lu, Sedat ^a   Özgür, Orhan ^a   Teletar, Hasan ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b School of Medicine ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CHRONIC KIDNEY FAILURE; EYELASH; HEMOLYTIC ANEMIA; HEPATITIS B; HUMAN; HYPERTRICHOSIS; INTERSTITIAL PNEUMONIA; MALE; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; THYROID DISEASE;

ADULT; ANTIVIRAL AGENTS; HEPATITIS B, CHRONIC; HUMANS; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON ALFA-2B; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE;

HEPATITIS B VIRUS;

EID: 1642586695     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000414808     Document Type: Article

References (13)

1. YOUNOSSI, Z.M., BRAUN, W.E., PRATIVA, D.E., GIFFORD, R.W., and STRAFFON, R.A. (1999). Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years. Transplantation 67, 271-275.
2. YAGISAWA, T., TOME, H., TANABE, K., SHIKAWA, N., TOKUMATO, N., et al. (.1997). Long-term outcome of hepatitis B surface antigen positive patients in the cytosporin era. Am. J. Nephrol. 17, 440-444.
3. DIANZANI, F., ANTONELLI, G., and CAPOBIANCHI, M.R. (1990). The biological basis for the clinical use of interferon. J. Hepatol. 11 (Suppl 1), S5-S10.
4. LINO, S. (1993). High-dose interferon treatment in chronic hepatitis C. Gut 34 (Suppl 2), S114-S118.
5. TOSTI, A., MISCIALI, C., BARDAZZI, F., FANTI, P.A., and VAROTTI, C. (1992). Telogen effluvium due to recombinant interferon alpha-2b. Dermatology 184, 124-125.
6. QUESADA, J.R., TALPAZ, M, RIOS, A., KURZROCK, R., and GUTTERMAN, J.U. (1986). Clinical toxicity of interferons in cancer patients: a review. J. Clin. Oncol. 4, 234-243.
7. VIAL, T., and DESCOTES, J. (1994). Clinical toxicity of the interferons. Drug Experience 10, 115-150.
8. RENAULT, P.R.F., and HOOFNAGLE, J.H. (1989). Side effects of alpha interferon. Semin. Liver Dis. 9, 273-277.
9. MCDONALD, E.M., MANN, A.H., and THOMAS, H.C. (1987). Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant gamma interferon hepatitis B carriers. Lancet 2, 1175-1177.
10. ROONBLOM, L.E., ALM, G.V., and OBERG, K.E. (1991). Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann. Intern. Med. 115, 178-183.
11. MACFARLAND, I.G., SMITH, H.M., JOHNSON, P.J., BRAY, G.P., VERGANI, D., and WILLIAMS, R. (1990). Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or falsepositive result? Lancet 335, 754-757.
12. FOON, K.A., and DOUCHER, G. (1984). Increased growth of eyelashes in a patient given leukocyte α interferon. N. Engl. J. Med. 311, 1259.
13. BERGLUND. E.F., BURTON, G.V., MILLS, G.M., and NICHOLS, G.M. (1990). Hypertrichosis of the eyelashes associated with interferon alpha therapy for chronic granulocytic leukemia. South. Med. J. 83, 306.